Oct 15 (Reuters) – Anavex Life Sciences Corp: * ANAVEX RECEIVES FDA CLEARANCE OF ITS IND APPLICATION FOR BLARCAMESINE IN FRAGILE X SYNDROME * ANAVEX LIFE SCIENCES CORP – IND FOR BLARCAMESINE IN
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Corrects paragraph 7 to say that chats about whom or what to vote for accounted…
* UN must risk failure for peace, Grynspan tells Reuters * She says quiet diplomacy…
By Juveria Tabassum Oct 15 (Reuters) - Fast-food chain KFC on Thursday signed Coca-Cola as…
Oct 15 (Reuters) - Thoma Bravo-owned cybersecurity company Proofpoint will buy data security firm Varonis…
Oct 15 (OPTA) - Summaries for the UEFA Europa League on Thursday (start times are…
By Milana Vinn and Anirban Sen NEW YORK, Oct 15 (Reuters) - Some current Anthropic investors…